One Year After Founder's Death, Armani Navigates Succession and Planned Stake Sale

One year after the death of its founder Giorgio Armani, the iconic Italian fashion house is navigating a critical transition defined by his succession plan and the strategic challenge of brand evolution. The company is now preparing for an initial stake sale, a process outlined in the late designer's will, amid a cautious global luxury market.

A Mandated Timeline for a Sale

Giorgio Armani, who passed away on September 4, 2025, at age 91, stipulated in his will that a sale of approximately 15% of the company should occur between 12 and 18 months after his death. This would be followed by a larger stake disposal or a stock market listing. The group is working with Rothschild as a financial adviser for the sale, according to sources cited by Reuters.

Bankers and advisers consulted by Reuters estimate the group's valuation at between €5 billion and €7 billion. However, sources close to the matter indicated the deadlines in the will are not strictly binding and that a deal could be postponed if market conditions do not support an adequate valuation.

Balancing Legacy and Evolution

While the company has focused on governance over the past year, analysts warn it must now pivot to strategic evolution to maintain relevance. In a sign of the challenges, Armani's sales declined 2.8% at constant currencies to €2.2 billion ($2.56 billion) last year. The company held €500 million in net cash at the end of 2025, as reported by Reuters.

Ad

CEO Giuseppe Marsocci, a group veteran, stated in July that the company is in a transition phase and would not pursue short-term fixes, remaining faithful to the founder's vision. "The great challenge will be maintaining the balance between the identity that defines us and the inevitable evolution we will have to pursue," Marsocci said. The new board includes former Gucci CEO Marco Bizzarri to help guide this process.

Potential Suitors and Strategic Interests

Armani's will identified several potential buyers, including France’s LVMH and key licensees EssilorLuxottica and L’Oréal. Each has distinct strategic interests in a potential deal:

• L'Oréal and EssilorLuxottica: A stake would help these partners protect lucrative licensing agreements for beauty and eyewear, which generated nearly €2 billion in revenue for them last year. L'Oréal told Reuters it would "study this opportunity" when discussions open.
• LVMH: The luxury conglomerate has reportedly studied a stand-alone investment. However, LVMH's preference for controlling its brands could be complicated if Armani's heirs opt for an IPO, a source with knowledge of the matter told Reuters.